BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6340492)

  • 1. Cell lineage in lymphoproliferative disease.
    Aisenberg AC
    Am J Med; 1983 Apr; 74(4):679-85. PubMed ID: 6340492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of T and B cell populations in some lymphoproliferative disorders.
    Herzog P; Stöckbauer P
    Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human T-cell leukemias: clinical, cytomorphologic, immunophenotypic, and genotypic characteristics.
    Knowles DM
    Hum Pathol; 1986 Jan; 17(1):14-33. PubMed ID: 3002948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2. Lymphocyte surface marker studies in lymphoma and leukemia.
    Lowenthal RM
    Pathology; 1982 Jul; 14(3):283-9. PubMed ID: 6752833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal immunoglobulins and B cell lymphoproliferative disorders.
    Sugai S; Takiguchi T; Konda S
    Nihon Ketsueki Gakkai Zasshi; 1984 Dec; 47(8):1604-15. PubMed ID: 6335808
    [No Abstract]   [Full Text] [Related]  

  • 6. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets.
    Aisenberg AC; Bloch KJ; Wilkes BM
    J Exp Med; 1981 Nov; 154(5):1709-14. PubMed ID: 6975352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.
    Aisenberg AC
    N Engl J Med; 1981 Feb; 304(6):331-6. PubMed ID: 6969365
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic lymphocytic leukemia B-lymphocytes forming SRBC-rosettes not due to an anti-SRBC activity of monoclonal surface immunoglobulin.
    Herrmann F; Kolecki P; Sieber G; Ludwig WD; Komischke B; Rühl H
    Am J Clin Pathol; 1985 Feb; 83(2):249-53. PubMed ID: 3871584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane phenotypic studies in B cell lymphoproliferative disorders.
    Scott CS; Limbert HJ; MacKarill ID; Roberts BE
    J Clin Pathol; 1985 Sep; 38(9):995-1001. PubMed ID: 2413082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of immunotyping in chronic lymphocytosis: review of the natural history of the condition in 145 adult patients.
    Tefferi A; Li CY; Phyliky RL
    Mayo Clin Proc; 1988 Aug; 63(8):801-6. PubMed ID: 2456433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody studies in B-cell chronic lymphocytic leukemia and allied disorders.
    Aisenberg AC; Wilkes BM
    Hematol Oncol; 1983; 1(1):13-9. PubMed ID: 6610619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sheep erythrocyte rosette formation by B chronic lymphocytic leukemia cells as a consequence of monoclonal surface immunoglobulin with "Forssman-like" antibody activity.
    Deegan MJ; Hayashi H; Sawdyk MA
    Am J Clin Pathol; 1983 Jul; 80(1):69-74. PubMed ID: 6602541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
    Royston I; Majda JA; Baird SM; Meserve BL; Griffiths JC
    J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of surface markers in chronic lymphocytic leukemia to acute lymphocytic leukemia.
    Aisenberg AC; Wilkes BM
    Cancer Res; 1981 Nov; 41(11 Pt 2):4810-3. PubMed ID: 6975164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of cell-surface markers in chronic lymphocytic leukaemia (CLL).
    Rak K; Pecze K; Kiss A; Telek B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):294-300. PubMed ID: 6205953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
    Han T; Ozer H; Minowada J
    Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunofluorescent demonstration of lymphocyte surface Markers.
    Holborow EJ; Papamichail M; Sheldon PJ
    Pathol Biol (Paris); 1975 Jun; 23(6):476-8. PubMed ID: 1105348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T- and B-lymphocytes in lymphoproliferative diseases].
    Tsveibakh AS; Gol'dman EI
    Vopr Onkol; 1978; 24(1):11-6. PubMed ID: 305684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual B and T markers in acute and chronic lymphocytic leukemia.
    Foon KA; Billing RJ; Terasaki PI
    Blood; 1980 Jan; 55(1):16-20. PubMed ID: 6965347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.